Papers
3
Total Citations
123
H-Index
3
About
Felix Hilpert is a gynecologic oncologist whose research has made significant contributions to the understanding and clinical management of borderline ovarian tumors (BOT), a relatively rare and historically understudied gynecological malignancy. His most impactful work centers on the multicenter AGO ROBOT study, a landmark pattern-of-care investigation that brought rigorous, large-scale analysis to a field previously dominated by small retrospective trials. Through this collaborative framework, Hilpert and colleagues examined clinical outcomes across nearly a thousand patients, illuminating how factors such as age and surgical staging influence prognosis. His 2014 sub-analysis exploring age-dependent differences in BOT patients has garnered 75 citations, reflecting its value to clinicians navigating treatment decisions across diverse patient populations. His subsequent 2015 work on surgical staging reinforced that incomplete staging procedures carry meaningful prognostic consequences, offering actionable guidance for surgical planning. Collectively, Hilpert's research has helped elevate the evidence base for BOT management from anecdotal to data-driven, earning recognition across the gynecologic oncology community. His contributions exemplify how carefully designed multicenter studies can reshape clinical standards and meaningfully improve patient outcomes in rare cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3